4 Biotechs That Were Winners at ASH

4 Biotechs That Were Winners at ASH

Submitted by admin on January 3, 2022 - 10:38am
Source: 
Motley Fool
News Tags: 
ASH2021
Bristol Myers Squibb
Agios Pharmaceuticals
Forma Therapeutics
Bluebird Bio
sickle cell disease
Multiple Myeloma
Headline: 
4 Biotechs That Were Winners at ASH
snippet: 
  • Bristol Myers Squibb presented positive data for two promising multiple myeloma therapies.
  • Agios Pharmaceuticals and Forma Therapeutics had dueling data for their respective sickle cell disease drugs.
  • Bluebird Bio also reported strong data for its sickle cell disease therapy.

Do Not Allow Advertisers to Use My Personal information